Further analyses showed that metastatic cases tended to have lower SLC25A38 expression and higher levels of molecules involving in cell proliferation, cell adhesion, cell motility, and angiogenesis compared to non-metastatic tumors in both TCGA cohort and GSE22138 cohort (Fig. 3F). This evidence concerns the gene SLC25A38 and metastatic neoplasm.